In a 2×2 factorial design, they were randomized to receive the cardioselective β-blocker bisoprolol (starting at 2.5 mg daily) or no bisoprolol and to receive fluvastatin (Lescol; 80 mg daily ...
Fluvastatin is an HMG-CoA reductase inhibitor, also known as a "statin", prescribed for high cholesterol and triglycerides in certain patients, and decreases the blockages in blood vessels.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results